China, Aug. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A real-word study of biosimilar denosumab (Rukexin)'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600130225
Registration Time: 2026/08/17
Type: Interventional study
Primary Sponsor: Peking University Third Hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=258660
Published by HT Digital Content Services with permission from Health Daily Digest....